Genmab Announces Data to be Presented at 2018 ASCO Annual Meeting

NEXT STORY
Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
PREV STORY
Teladoc Announces U.S. Launch of Behavioral Health Navigator
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Grokker Extends Free Access to Companies to Support Workforce Wellbeing During COVID-19 Outbreak

author_avatar
NASDAQ Market News

Chembio Diagnostics Receives FDA Approval for DPP HIV-Syphilis System

author_avatar
NASDAQ Market News

OraSure Technologies Reports 3Q21 Revenue of $53.9 Million, Signs Three Major U.S. Government Contracts Positioning the Company for Significant InteliSwab™ Growth in FY22

author_avatar
NASDAQ Market News